MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-10-0006883
Silver Salt Pharmaceuticals Private Limited
Silver Salt Pharmaceuticals Private Limited - pharma in Karnal, Haryana, India. Directors, charges & compliance details.
Revenue · FY 2023
₹50.67 Lakh
▲ 129% YoY
Net loss · FY 2023
₹20.73 Lakh
Net margin -40.9%
EBITDA · FY 2023
-₹18.64 Lakh
EBITDA margin -36.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
4
As per MCA filings
About Silver Salt Pharmaceuticals Private Limited
Data last updated:
Silver Salt Pharmaceuticals Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299HR2020PTC090019.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rajiv Malhotra and Vijay Kohli.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 71/3 Hsidc, Karnal, Haryana, India – 132001.
As per the financials filed for FY 2023, the company reported a revenue of ₹50.67 Lakh, a growth of 129% compared to the previous year. For the same year it recorded a net loss of ₹20.73 Lakh (net margin -40.9%) and EBITDA of -₹18.64 Lakh (EBITDA margin -36.8%).
As per MCA filings, the company has open charges of ₹20 Lakh on record.
Silver Salt Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0006883).
Company details
CIN U24299HR2020PTC090019
Registration Number 090019
Incorporation Date 12 October 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-HR-10-0006883
Recognitions & Rankings of Silver Salt Pharmaceuticals
Contact details
Silver Salt Pharmaceuticals Private Limited's registered office is in Karnal, Haryana.
- Registered Address71/3 Hsidc, Karnal, Haryana, India – 132001
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Silver Salt Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Silver Salt Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Silver Salt Pharmaceuticals Private Limited, buy the company report.
Financials of Silver Salt Pharmaceuticals Private Limited
FY 2025 filings availableSilver Salt Pharmaceuticals Private Limited reported revenue of ₹50.67 Lakh (up 129% YoY) for FY 2023.
Revenue · FY 2023
₹50.67 Lakh ▲ 129%
Net loss · FY 2023
₹20.73 Lakh margin -40.9%
EBITDA · FY 2023
-₹18.64 Lakh margin -36.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 129%
EBITDA CAGR growth
1 year
▼ 138%
Revenue rose 129% in the latest year. EBITDA fell 138% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹18.64 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹20.73 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -36.8% | ||
| Net Profit Margin | -40.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Silver Salt Pharmaceuticals Private Limited, buy the company report.
Board of directors of Silver Salt Pharmaceuticals Private Limited
Silver Salt Pharmaceuticals has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajiv Malhotra | Director | 12 Oct 2020 | 6 Years 1 Months | Current |
| Vijay Kohli | Director | 12 Oct 2020 | 6 Years 1 Months | Current |
| Viney Kohli | Director | 12 Oct 2020 | 6 Years 1 Months | Current |
| Anil Malhotra | Director | 12 Oct 2020 | 6 Years 1 Months | Current |
Charges & borrowings
Open charges
₹20 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Nov 2021 | 100516439 | Hdfc Bank Limited | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Silver Salt Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Silver Salt Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Silver Salt Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Silver Salt Pharmaceuticals Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Anil Malhotra was appointed as Director on 12 Oct 2020.
AGM
Silver Salt Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Silver Salt Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.00 Lakh with Charge ID 100516439 was registered on 23 Nov 2021.
Appointed
Anil Malhotra was appointed as Director.
Appointed
Rajiv Malhotra was appointed as Director.
Appointed
Vijay Kohli was appointed as Director.
Appointed
Viney Kohli was appointed as Director.
Incorporation
12 Oct 2020
Silver Salt Pharmaceuticals Private Limited was registered on 12 Oct 2020 with Roc Delhi & aged 6 years 1 month as per MCA records.
Frequently asked questions
Silver Salt Pharmaceuticals is an active private limited company based in Karnal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 October 2020 (6+ years old) and is registered under CIN U24299HR2020PTC090019.
Silver Salt Pharmaceuticals has 4 current directors:
- Rajiv Malhotra - Director
- Vijay Kohli - Director
- Viney Kohli - Director
- Anil Malhotra - Director
The latest financial statements of Silver Salt Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Silver Salt Pharmaceuticals is U24299HR2020PTC090019. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Silver Salt Pharmaceuticals was incorporated on 12 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Anil Malhotra was appointed as Director on 12 Oct 2020. Rajiv Malhotra was appointed as Director on 12 Oct 2020. Vijay Kohli was appointed as Director on 12 Oct 2020. Silver Salt Pharmaceuticals has 4 board changes on record in total.
Yes, Silver Salt Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-10-0006883).
The registered office of Silver Salt Pharmaceuticals is at 713 Hsidc, Karnal, Haryana, India – 132001.
Silver Salt Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Silver Salt Pharmaceuticals has open charges of ₹20 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages